News Posts List
New drug regimen that reduces toxicities
03/19/2015
The seven-year study began in 2007 and the findings revolutionized the standard protocol for patient management in NCCS with an attenuated-dose regimen of sunitinib for patients with mRCC.
African bush may help kidney cancer treatment
03/17/2015
Professor Beech said: "This unexpected discovery is exciting because it means we could develop new cancer drugs towards these particular proteins, TRPC4 and TRPC5.
Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors
03/17/2015
Obesity is one of the leading risk factors for developing renal cell carcinoma, an immunogenic tumor that is treated clinically with immunostimulatory therapies. Currently, however, the mechanisms linking obesity with renal cancer incidence are unclear.
Trends in Renal Cell Carcinoma Incidence and Mortality
03/16/2015
Renal cell carcinoma (RCC) incidence rates are higher in developed countries, where up to half of the cases are discovered incidentally. Declining mortality trends have been reported in highly developed countries since the 1990s.
A new study for people with Renal Cell Carcinoma (RCC)
03/04/2015
This study will explore the effectiveness of the experimental drug known as CRLX101 combined with bevacizumab (Avastin), in patients with metastatic renal cell carcinoma (RCC).
Kidney Cancer Update (PDF)
03/03/2015
Starting with this issue, Clinical Advances in Hematology & Oncology is launching a bimonthly column on kidney cancer in conjunction with the Kidney Cancer Association. The column will include information about the state of research, advances in treatment, and other news for oncologists who treat patients with kidney cancer. We will begin with an overview of the Kidney Cancer Association and its mission.
Exercise and Cancer
03/03/2015
How does exercise benefit cancer patients? It turns out that there are a number of different reasons why exercise has such a positive impact on cancer patients. The immune system becomes more activated during exercise...
Novartis completes series of transactions with GSK
03/03/2015
Novartis has completed a series of transactions with GlaxoSmithKline (GSK), including the acquisition of certain oncology products and pipeline compounds from GSK, the creation of a world-leading consumer healthcare business through a joint venture...
Lycopene may ward off kidney cancer in older women
03/03/2015
A higher intake by postmenopausal women of the natural antioxidant lycopene, found in foods like tomatoes, watermelon and papaya, may lower the risk of renal cell carcinoma...
Combination Therapy with Sunitinib and Gemcitabine in Rapidly Progressive mRCC
03/01/2015
Standard single-agent treatment options offer meager prospects for metastatic sarcomatoid renal cell carcinoma (RCC) and poor-risk RCC, both of which demonstrate aggressive tumor biology and rapid clinical disease progression. However, results of a single-arm, open-label, phase II trial suggest that combining select treatment options may deliver the necessary punch to keep these aggressive forms of RCC in check (Abstract 408).
News Feed